Major advances in bipolar disorder

被引:15
|
作者
Mitchell, PB
Malhi, GS
Ball, JLR
机构
[1] Univ New S Wales, Sch Psychiat, Randwick, NSW 2031, Australia
[2] Prince Wales Hosp, Black Dog Inst, Sydney, NSW, Australia
关键词
D O I
10.5694/j.1326-5377.2004.tb06238.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There have been major advances in clinical understanding and treatment of bipolar disorder over the past decade. Randomised controlled trials of pharmacological treatments and psychological interventions have shown that there are effective short-term and long-term treatments for the disorder. Despite advances in treatment, diagnosis is often delayed or mistaken, and many people who could benefit are not using the treatments available. Functional and symptomatic recovery from episodes of bipolar disorder is frequently less complete than previously considered, and disability is often profound. Although manic episodes are the distinguishing feature of bipolar disorder, it appears that depression is the predominant mood disturbance and that much of the functional impairment associated with bipolar disorder results from this. Comorbidity with anxiety disorders or substance misuse is common. Advances in genetics, brain imaging and basic pharmacology are starting to provide understanding of the complex causative processes.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [21] Subcortical volumes differentiate Major Depressive Disorder, Bipolar Disorder, and remitted Major Depressive Disorder
    Sacchet, Matthew D.
    Livermore, Emily E.
    Iglesias, Juan Eugenio
    Glover, Gary H.
    Gotlib, Ian H.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 68 : 91 - 98
  • [22] Symposium - Recent advances in juvenile bipolar disorder
    Hazell, Philip
    Mahli, Gin
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 : A30 - A30
  • [24] Bipolar disorder not otherwise specified: Comparison with bipolar disorder I/II and major depression
    Joyce, Peter R.
    Light, Katrina J.
    Rowe, Sarah L.
    Kennedy, Martin A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (10): : 843 - 849
  • [25] Advances in the psychopharmacotherapy of bipolar disorder type I
    Sleem, Ahmad
    El-Mallakh, Rif S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (10) : 1267 - 1290
  • [26] Bipolar disorder and advances in neuroimaging: A progressive match
    Strakowski, SM
    CNS SPECTRUMS, 2006, 11 (04) : 267 - 268
  • [27] Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder
    Richards, Alexander L.
    Cardno, Alastair
    Harold, Gordon
    Craddock, Nicholas J.
    Di Florio, Arianna
    Jones, Lisa
    Gordon-Smith, Katherine
    Jones, Ian
    Sellers, Ruth
    Walters, James T. R.
    Holmans, Peter A.
    Owen, Michael J.
    O'Donovan, Michael C.
    JAMA PSYCHIATRY, 2022, 79 (10) : 1032 - 1039
  • [28] Advances in Biomarkers of Major Depressive Disorder
    Huang, Tiao-Lai
    Lin, Chin-Chuen
    ADVANCES IN CLINICAL CHEMISTRY, VOL 68, 2015, 68 : 177 - 204
  • [29] Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder
    Serretti, Alessandro
    Chiesa, Alberto
    Calati, Raffaella
    Linotte, Sylvie
    Sentissi, Othman
    Papageorgiou, Konstantinos
    Kasper, Siegfried
    Zohar, Joseph
    De Ronchi, Diana
    Mendlewicz, Julien
    Amital, Daniela
    Montgomery, Stuart
    Souery, Daniel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2013, 263 (02) : 93 - 103
  • [30] Lumateperone Treatment for Major Depressive Episodes With Mixed Features in Major Depressive Disorder and Bipolar I or Bipolar II Disorder
    Earley, Willie
    Durgam, Suresh
    Kozauer, Susan G.
    Chen, Changzheng
    Huo, Jason
    Stahl, Stephen
    McIntyre, Roger S.
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 198 - 198